Literature DB >> 66321

Human lung organ-specific antigens on normal lung, lung tumors, and a lung tumor cell line.

R Akeson.   

Abstract

An antiserum raised in rabbits against a lung tumor cell line (2563) was selected from a library of antisera against normal and malignant human lung, lung tumor cell lines, and fetal tissues and was found by complement fixation, immunofluorescence, and saturation binding assays to contain antibodies for antigens characteristic of those found in normal lung. Studies with the adsorbed antiserum (A49) revealed: 1) An antigen was shared by normal lung and normal kidney (NLK-1) 2) lung tissue-specific antigen(s) were present on normal lung tissue (NL-1); 3) NL-1 was found on both external and internal cell membranes; and 4) NL-1, in addition to being present on normal lung and the adenocarcinoma-derived cell line 2563, was present on 1 of 2 metastatic lung adenocarcinomas but on none of 4 metastatic lung tumors of other histologic types.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 66321     DOI: 10.1093/jnci/58.4.863

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  5 in total

1.  Wilms' tumor cell line.

Authors:  W A Nelson-Rees
Journal:  In Vitro       Date:  1979-10

Review 2.  Lymphocytes. 2. Differentiation. Differentiation of lymphoid precursor cells.

Authors:  G Janossy; G Pizzolo
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1979

3.  Monoclonal antibodies that demonstrate specificity for several types of human lung cancer.

Authors:  F Cuttitta; S Rosen; A F Gazdar; J D Minna
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

Review 4.  Immunohistochemical techniques and their applications in the histopathology of the respiratory system.

Authors:  I Linnoila; P Petrusz
Journal:  Environ Health Perspect       Date:  1984-06       Impact factor: 9.031

5.  An improved antigenic marker of human lung carcinomas and its use in radioimmunoassays.

Authors:  A Wolf; M Micksche; H Bauer
Journal:  Br J Cancer       Date:  1981-03       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.